Creative Medical Technology Holdings Inc. (NASDAQ: CELZ ) shares are surging Thursday afternoon following an intellectual property milestone .
Creative Medical Tech stock is showing exceptional strength. What’s fueling CELZ momentum?Broadening IP Protection for Cell-Free Exosome Technology
The clinical-stage biotechnology firm announced it received a Notice of Allowance from the USPTO for its patent application titled “Suppression of Diabetes Using Exosomes From Stem Cell Programmed Myeloid Cells.”
Once issued, the company says the new patent strengthens protection around Creative Medical’s MyeloCelz platform. Creative Medical says the cell-free technology utilizes stem-cell-programmed myeloid cells to induce immune tolerance and stop the autoimmune destruction of insulin-producing pancreatic beta cells.
This addition builds on a portfolio of roughly 60 issued patents and pending applications.
Management Commentary and Market Potential
CELZ Shares Surge Thursday Afternoon
CELZ Price Action: Creative Medical Tech shares were up 104.67% at $1.36 at the time of publication on Thursday, according to Benzinga Pro data .
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here .
Posted In: Trading Ideas Movers News why it's moving Retail Investor Stocks